Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

273

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

273 results for “Hyperglycemia”

Learn how ShareScore rates datasets ↗
zenodo44/100

Single-cell transcriptomic profiling unveils dysregulation of cardiac progenitor cells and cardiomyocytes in a mouse model of maternal hyperglycemia

<p>Congenital heart disease (CHD) is the most prevalent structural malformations of the heart affecting &sim;1% of live births. To date, both damaging genetic variations and adverse environmental exposure such as maternal diabetes have been found to cause CHD. Clinical studies show &sim;fivefold higher risk of CHD in the offspring of mothers with pregestational diabetes. Maternal pregestational diabetes affects the gene regulatory networks key to proper cardiac development in the fetus. However, the cell-type specificity of these gene regulatory responses to maternal diabetes and their association with the observed cardiac defects in the fetuses remains unknown. To uncover the transcriptional responses to maternal diabetes in the early embryonic heart, we used an established murine model of pregestational diabetes. In this model, we have previously demonstrated an increased incidence of CHD. Here, we show maternal hyperglycemia (matHG) elicits diverse cellular responses during heart development by single-cell RNA-sequencing in embryonic hearts exposed to control and matHG environment. Through differential gene-expression and pseudotime trajectory analyses of this data, we identified changes in lineage specifying transcription factors, predominantly affecting Isl1+ second heart field progenitors and Tnnt2+cardiomyocytes with matHG. Using in vivo cell-lineage tracing studies, we confirmed that matHG exposure leads to impaired second heart field-derived cardiomyocyte differentiation. Finally, this work identifies matHG-mediated transcriptional determinants in cardiac cell lineages elevate CHD risk and show perturbations in Isl1-dependent gene-regulatory network (Isl1-GRN) affect cardiomyocyte differentiation. Functional analysis of this GRN in cardiac progenitor cells will provide further mechanistic insights into matHG-induced severity of CHD associated with diabetic pregnancies.</p>

opencc-by-4.0Jun 2024View details →
zenodo40/100

Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India

<p><strong>Abstract</strong></p> <p><strong><em>BACKGROUND</em></strong></p> <p>In the context of the ongoing COVID-19 pandemic increased incidence of ROCM was noted in India, among those infected with COVID. We determined risk factors for rhino-orbito-cerebral mucormycosis (ROCM) post Coronavirus disease 2019 (COVID-19) among those never and ever hospitalized for COVID-19 separately through a multi-centric, hospital-based, unmatched case-control study across India.</p> <p><strong><em>METHODS</em></strong></p> <p>We defined cases and controls as those with and without post-COVID ROCM, respectively. We compared their socio-demographics, comorbidities, steroid use, glycaemic status, and practices. We calculated crude and adjusted odds ratio (AOR) with 95% confidence intervals (CI) through logistic regression. The covariates with p-value for crude OR of less 0&middot;20 were considered for the regression model.</p> <p><strong><em>RESULTS</em></strong></p> <p>Among hospitalised, we recruited 267 cases and 256 controls and 116 cases and 231 controls among never hospitalised. Risk factors (AOR; 95% CI) for post-COVID ROCM among the hospitalised were age 45-59 years (2&middot;1; 1&middot;4 to 3&middot;1), having diabetes mellitus (4&middot;9; 3&middot;4 to 7&middot;1), elevated plasma glucose (6&middot;4; 2&middot;4 to 17&middot;2), steroid use (3&middot;2; 2 to 5&middot;2) and frequent nasal washing (4&middot;8; 1&middot;4 to 17). Among those never hospitalised, age &ge; 60 years (6&middot;6; 3&middot;3 to 13&middot;3), having diabetes mellitus (6&middot;7; 3&middot;8 to 11&middot;6), elevated plasma glucose (13&middot;7; 2&middot;2 to 84), steroid use (9&middot;8; 5&middot;8 to 16&middot;6), and cloth facemask use (2&middot;6; 1&middot;5 to 4&middot;5) were associated with increased risk of post-COVID ROCM.</p> <p><strong><em>CONCLUSIONS</em></strong></p> <p>Hyperglycemia irrespective of having diabetes mellitus and steroid use was associated with increased risk of ROCM independent of COVID-19 hospitalisation. Rational steroid usage and glucose monitoring may reduce the risk of post-COVID.</p>

opencc-by-4.0Jun 2022View details →
ClinicalTrials.gov40/100

Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

ClinicalTrials.gov study NCT02060383. IPD Sharing: YES. Countries: 12. Publications: 2.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Hyperglycemia in Renal Transplantation

ClinicalTrials.gov study NCT01643382. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Green Tea Confections For Managing Postprandial Hyperglycemia-Induced Vascular Endothelial Dysfunction

ClinicalTrials.gov study NCT01857258. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Insulin for Hyperglycemia in Stroke Trial

ClinicalTrials.gov study NCT04834362. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes

ClinicalTrials.gov study NCT01159938. IPD Sharing: Not stated. Countries: 1. Publications: 3.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Effects of a Complete Diet in Critically Ill Patients With Stress Hyperglycemia

ClinicalTrials.gov study NCT01233726. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults

ClinicalTrials.gov study NCT03520569. IPD Sharing: NO. Countries: 1. Publications: 31.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Benefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 Diabetes

ClinicalTrials.gov study NCT02408120. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Metformin and Transient Hyperglycemia

ClinicalTrials.gov study NCT01486043. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Golden Rice Cookies With Piper Crocatum for Blood Glucose Control and Quality of Life in People Living With HIV With Hyperglycemia

ClinicalTrials.gov study NCT07187648. IPD Sharing: NO. Countries: 0. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia

ClinicalTrials.gov study NCT03511521. IPD Sharing: NO. Countries: 1. Publications: 5.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes

ClinicalTrials.gov study NCT00191282. IPD Sharing: Not stated. Countries: 17. Publications: 4.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin

ClinicalTrials.gov study NCT01136746. IPD Sharing: Not stated. Countries: 1. Publications: 5.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

The Association Between Peri-Operative Hyperglycemia and Major Morbidity and Mortality

ClinicalTrials.gov study NCT00487162. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)

ClinicalTrials.gov study NCT02971202. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes

ClinicalTrials.gov study NCT02269098. IPD Sharing: NO. Countries: 1. Publications: 3.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Impact of Fenugreek Supplementation on Obesity and Hyperglycemia Among Diabetic Adults in Saudi Arabia

ClinicalTrials.gov study NCT07038577. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients

ClinicalTrials.gov study NCT05442853. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record